112 related articles for article (PubMed ID: 2208002)
1. Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancer.
Kragel AH; Travis WD; Steis RG; Rosenberg SA; Roberts WC
Cancer; 1990 Oct; 66(7):1513-6. PubMed ID: 2208002
[TBL] [Abstract][Full Text] [Related]
2. Severe myocarditis following high-dose interleukin-2 administration.
Samlowski WE; Ward JH; Craven CM; Freedman RA
Arch Pathol Lab Med; 1989 Aug; 113(8):838-41. PubMed ID: 2787976
[TBL] [Abstract][Full Text] [Related]
3. Case report and brief review: IL-2-induced myocarditis.
Eisner RM; Husain A; Clark JI
Cancer Invest; 2004; 22(3):401-4. PubMed ID: 15493361
[TBL] [Abstract][Full Text] [Related]
4. Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patients.
Kragel AH; Travis WD; Feinberg L; Pittaluga S; Striker LM; Roberts WC; Lotze MT; Yang JJ; Rosenberg SA
Hum Pathol; 1990 May; 21(5):493-502. PubMed ID: 2338330
[TBL] [Abstract][Full Text] [Related]
5. [Anatomopathological findings correlated with high-dose recombinant interleukin-2. Review of the literature and description of 2 autopsy cases].
Canzonieri V; Monfardini S; Carbone A
Pathologica; 1992; 84(1092):473-81. PubMed ID: 1491889
[TBL] [Abstract][Full Text] [Related]
6. Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation.
Abbate A; Bussani R; Liuzzo G; Biondi-Zoccai GG; Barresi E; Mellone P; Sinagra G; Dobrina A; De Giorgio F; Sharma R; Bassan F; Severino A; Baldi F; Biasucci LM; Pandolfi F; Silvestri F; Vetrovec GW; Baldi A; Crea F
Heart; 2008 Jun; 94(6):737-42. PubMed ID: 17698556
[TBL] [Abstract][Full Text] [Related]
7. Late enhancement detected by cardiac magnetic resonance imaging in acute myocarditis mimicking acute myocardial infarction: location patterns and lack of correlation with systolic function.
Camastra GS; Cacciotti L; Marconi F; Sbarbati S; Pironi B; Ansalone G
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1029-33. PubMed ID: 18163015
[TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma.
Du Bois JS; Trehu EG; Mier JW; Shapiro L; Epstein M; Klempner M; Dinarello C; Kappler K; Ronayne L; Rand W; Atkins MB
J Clin Oncol; 1997 Mar; 15(3):1052-62. PubMed ID: 9060545
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
[TBL] [Abstract][Full Text] [Related]
10. Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma.
Thavendiranathan P; Verhaert D; Kendra KL; Raman SV
Br J Radiol; 2011 May; 84(1001):e99-e102. PubMed ID: 21511746
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy: a case report.
Truica CI; Hansen CH; Garvin DF; Meehan KR
Cancer; 1998 Sep; 83(6):1231-6. PubMed ID: 9740090
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic myocarditis occurs with myocardial infarction and coincides with increased inflammation, hemorrhage and instability in coronary artery atherosclerotic plaques.
Woudstra L; Biesbroek PS; Emmens RW; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA
Int J Cardiol; 2017 Apr; 232():53-62. PubMed ID: 28087177
[TBL] [Abstract][Full Text] [Related]
13. Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data.
Tornvall P; Gerbaud E; Behaghel A; Chopard R; Collste O; Laraudogoitia E; Leurent G; Meneveau N; Montaudon M; Perez-David E; Sörensson P; Agewall S
Atherosclerosis; 2015 Jul; 241(1):87-91. PubMed ID: 25967935
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of the Evolution of Immune Checkpoint Inhibitor Myocarditis With Cardiovascular Magnetic Resonance.
Sato T; Nakamori S; Watanabe S; Nishikawa K; Inoue T; Imanaka-Yoshida K; Ishida M; Sakuma H; Ito M; Dohi K
Circ Cardiovasc Imaging; 2020 Nov; 13(11):e010633. PubMed ID: 33153280
[No Abstract] [Full Text] [Related]
15. Severe reversible global and regional ventricular dysfunction associated with high-dose interleukin-2 immunotherapy.
Du Bois JS; Udelson JE; Atkins MB
J Immunother Emphasis Tumor Immunol; 1995 Aug; 18(2):119-23. PubMed ID: 8574467
[TBL] [Abstract][Full Text] [Related]
16. Peripheral nerve entrapment: an unusual adverse event with high-dose interleukin-2 therapy.
Sikora SS; Samsonov ME; Dookeran KA; Edington H; Lotze MT
Ann Oncol; 1996 Jul; 7(5):535-6. PubMed ID: 8839913
[No Abstract] [Full Text] [Related]
17. Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases.
Baroldi G; Corallo S; Moroni M; Repossini A; Mutinelli MR; Lazzarin A; Antonacci CM; Cristina S; Negri C
J Am Coll Cardiol; 1988 Aug; 12(2):463-9. PubMed ID: 3392340
[TBL] [Abstract][Full Text] [Related]
18. Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients.
Ansari-Gilani K; Tirumani SH; Smith DA; Nelson A; Alahmadi A; Hoimes CJ; Ramaiya NH
Emerg Radiol; 2020 Aug; 27(4):455-460. PubMed ID: 32130542
[TBL] [Abstract][Full Text] [Related]
19. Possible myocardial toxicity associated with interleukin-4 therapy.
Trehu EG; Isner JM; Mier JW; Karp DD; Atkins MB
J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):348-51. PubMed ID: 8280718
[TBL] [Abstract][Full Text] [Related]
20. Ischemia, contraction band necrosis and myocarditis.
Welch RD
Ann Emerg Med; 1991 May; 20(5):591-2. PubMed ID: 2024805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
